First-Of-Its-Kind Clinical Trial To Study Psychedelic Treatments For PTSD In Veterans

Psychedelics-based treatments developer NeuroPharm Inc., a subsidiary of publicly traded Mydecine Innovations Group Inc., recently announced it would be collaborating with the Leiden University Medical Center of The Netherlands (LUMC) on clinical trials for the treatment of posttraumatic stress disorder (PTSD) in veterans.